Asset Management Corp Guardant Health, Inc. Transaction History

Asset Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$48.25 - $100.49 $129,503 - $269,715	-2,684 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$127.04 - $179.1 $57,168 - $80,595	-450 Reduced 14.36%	2,684 $410,000
Q4 2020 Jan 29, 2021	SELL	$99.96 - $135.93 $49,980 - $67,965	-500 Reduced 13.76%	3,134 $499,000
Q3 2020 Oct 26, 2020	SELL	$80.32 - $111.8 $16,063 - $22,360	-200 Reduced 5.22%	3,634 $406,000
Q2 2020 Jul 21, 2020	SELL	$60.49 - $97.5 $220,788 - $355,875	-3,650 Reduced 48.77%	3,834 $311,000
Q1 2020 Apr 14, 2020	SELL	$59.04 - $88.81 $187,452 - $281,971	-3,175 Reduced 29.79%	7,484 $521,000
Q4 2019 Feb 04, 2020	BUY	$59.49 - $82.78 $634,103 - $882,352	10,659 New	10,659 $833,000

424

126M

1.51M

2.35M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $9.45B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Asset Management Corp with notifications on news.